Rarecells

Rarecells

Biotechnology, 400 Farmington Ave, Paris, Connecticut, 06032, United States, 11-50 Employees

rarecells.com

  • LinkedIn

Who is RARECELLS

Rarecells develops and commercializes the ISET technology to isolate Circulating Cancer Cells for early cancer diagnosis and medical research. Rarecells Diagnostics was created in 2010 by...

Read More

map
  • 400 Farmington Ave, Paris, Connecticut, 06032, United States Headquarters: 400 Farmington Ave, Paris, Connecticut, 06032, United States
  • 2010 Date Founded: 2010
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: Under $1 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 7372 | NAICS Code: 513210 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from RARECELLS

Rarecells Org Chart and Mapping

Employees

Sofija Trajanovski

Senior Laboratory Technician / Ficccs Samples Coordinator

Similar Companies to Rarecells

Atomic AI

  • 11-50 11-50
  • 1 Billion and Over $ 1 Billion and Over

Exai Bio

  • 51-200 51-200
  • 1 Million to 5 Million $ 1 Million to 5 Million
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Rarecells

Answer: Rarecells's headquarters are located at 400 Farmington Ave, Paris, Connecticut, 06032, United States

Answer: Rarecells's official website is https://rarecells.com

Answer: Rarecells's revenue is Under $1 Million

Answer: Rarecells's SIC: 7372

Answer: Rarecells's NAICS: 513210

Answer: Rarecells has 11-50 employees

Answer: Rarecells is in Biotechnology

Answer: Rarecells top competitors include: Atomic AI , Exai Bio

Answer: Rarecells contact info: Phone number: Website: https://rarecells.com

Answer: Rarecells develops and commercializes the ISET technology to isolate Circulating Cancer Cells for early cancer diagnosis and medical research. Rarecells Diagnostics was created in 2010 by Patrizia Paterlini Brechot, Professor of Cell Biology and Oncology, in order to make the scientific and technological advances developed by her team available to research teams and patients. Rarecells Diagnostics core product is the patented ISET (Isolation by SizE of Tumor cells) Technology. Rarecells Diagnostics has the exclusive license of patents belonging to the French Public Institutions University Paris Descartes, Assistance Publique Hopitaux de Paris and INSERM protecting the Rarecells Device and its consumables, as well as the analyses performed on cells isolated using the Rarecells System. Rarecells Diagnostics is a science-driven company. We are scientists working for scientists and patients. We care about bringing benefits to the patients.The team delivers customer satisfaction by manufacturing high quality products and providing high-level scientific assistance. Rarecells and ISET are registered trademarks of Rarecells SAS.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access